ReP USP - Resultado da busca

Artigo de periodico
METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours (2022)
Glasberg, Joao; Talans, Aley; Giollo, Thomas Rivelli; Recchimuzzi, Debora Zachello; Bezerra Neto, Joao Evangelista; Lopez, Rossana Veronica Mendonza; Hoff, Paulo Marcelo Gehm ; Riechelmann, Rachel P
Source: Ecancermedicalscience. Unidade: FM
Subjects: NEUROENDOCRINOLOGIA, CARCINOMA NEUROENDÓCRINO, NEOPLASIAS, METFORMINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASBERG, Joao et al. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours. Ecancermedicalscience, v. 16, 2022Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2022.1369. Acesso em: 02 nov. 2024.
APA
Glasberg, J., Talans, A., Giollo, T. R., Recchimuzzi, D. Z., Bezerra Neto, J. E., Lopez, R. V. M., et al. (2022). METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours. Ecancermedicalscience, 16. doi:10.3332/ecancer.2022.1369
NLM
Glasberg J, Talans A, Giollo TR, Recchimuzzi DZ, Bezerra Neto JE, Lopez RVM, Hoff PMG, Riechelmann RP. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours [Internet]. Ecancermedicalscience. 2022 ; 16[citado 2024 nov. 02 ] Available from: https://doi.org/10.3332/ecancer.2022.1369
Vancouver
Glasberg J, Talans A, Giollo TR, Recchimuzzi DZ, Bezerra Neto JE, Lopez RVM, Hoff PMG, Riechelmann RP. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours [Internet]. Ecancermedicalscience. 2022 ; 16[citado 2024 nov. 02 ] Available from: https://doi.org/10.3332/ecancer.2022.1369
Artigo de periodico
High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease (2018)
Alves, Carolina; Mesquita, Marcella; Silva, Carolina; Soeiro, Maria; Hajjar, Ludhmila; Riechelmann, Rachel P
Source: Ecancermedicalscience. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, DIAGNÓSTICO TARDIO, TUMOR CARCINOIDE, CARCINOMA NEUROENDÓCRINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Carolina et al. High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease. Ecancermedicalscience, v. 12, 2018Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2018.879. Acesso em: 02 nov. 2024.
APA
Alves, C., Mesquita, M., Silva, C., Soeiro, M., Hajjar, L., & Riechelmann, R. P. (2018). High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease. Ecancermedicalscience, 12. doi:10.3332/ecancer.2018.879
NLM
Alves C, Mesquita M, Silva C, Soeiro M, Hajjar L, Riechelmann RP. High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease [Internet]. Ecancermedicalscience. 2018 ; 12[citado 2024 nov. 02 ] Available from: https://doi.org/10.3332/ecancer.2018.879
Vancouver
Alves C, Mesquita M, Silva C, Soeiro M, Hajjar L, Riechelmann RP. High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease [Internet]. Ecancermedicalscience. 2018 ; 12[citado 2024 nov. 02 ] Available from: https://doi.org/10.3332/ecancer.2018.879
Artigo de periodico
Recurrence-free survival as a putative surrogate for overall survival in phase. trials of curative-intent treatment of colorectal liver metastases: Systematic review (2017)
Araujo, Raphael L. C.; Herman, Paulo; Riechelmann, Rachel P
Source: World journal of clinical oncology. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, METÁSTASE NEOPLÁSICA, NEOPLASIAS HEPÁTICAS, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Raphael L. C. e HERMAN, Paulo e RIECHELMANN, Rachel P. Recurrence-free survival as a putative surrogate for overall survival in phase. trials of curative-intent treatment of colorectal liver metastases: Systematic review. World journal of clinical oncology, v. 8, n. 3, p. 266-272, 2017Tradução . . Disponível em: https://doi.org/10.5306/wjco.v8.i3.266. Acesso em: 02 nov. 2024.
APA
Araujo, R. L. C., Herman, P., & Riechelmann, R. P. (2017). Recurrence-free survival as a putative surrogate for overall survival in phase. trials of curative-intent treatment of colorectal liver metastases: Systematic review. World journal of clinical oncology, 8( 3), 266-272. doi:10.5306/wjco.v8.i3.266
NLM
Araujo RLC, Herman P, Riechelmann RP. Recurrence-free survival as a putative surrogate for overall survival in phase. trials of curative-intent treatment of colorectal liver metastases: Systematic review [Internet]. World journal of clinical oncology. 2017 ; 8( 3): 266-272.[citado 2024 nov. 02 ] Available from: https://doi.org/10.5306/wjco.v8.i3.266
Vancouver
Araujo RLC, Herman P, Riechelmann RP. Recurrence-free survival as a putative surrogate for overall survival in phase. trials of curative-intent treatment of colorectal liver metastases: Systematic review [Internet]. World journal of clinical oncology. 2017 ; 8( 3): 266-272.[citado 2024 nov. 02 ] Available from: https://doi.org/10.5306/wjco.v8.i3.266

USP Schools

ReP

Filtros

Authors

Subjects